ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Development of Receptor Binding Domain (RBD)-Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS-CoV-2 Delta and Other Variants.

Ran Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.